Related Experiment Video
Updated: Jul 12, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Erratum to "The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma" [Lung
H Wang1, J Agulnik2, G Kasymjanova2
1Divisions of Pathology & Molecular Genetics, McGill University Health Center, Montreal, QC, Canada; Department of Pathology, McGill University, Montreal, QC, Canada; Department of Medicine & Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
No abstract available in PubMed .
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021